685 related articles for article (PubMed ID: 29098871)
41. Recent development of chitosan-based polyelectrolyte complexes with natural polysaccharides for drug delivery.
Luo Y; Wang Q
Int J Biol Macromol; 2014 Mar; 64():353-67. PubMed ID: 24360899
[TBL] [Abstract][Full Text] [Related]
42. Lornoxicam controlled release transdermal gel patch: Design, characterization and optimization using co-solvents as penetration enhancers.
Hashmat D; Shoaib MH; Ali FR; Siddiqui F
PLoS One; 2020; 15(2):e0228908. PubMed ID: 32107483
[TBL] [Abstract][Full Text] [Related]
43. Development of gellan gum containing formulations for transdermal drug delivery: Component evaluation and controlled drug release using temperature responsive nanogels.
Carmona-Moran CA; Zavgorodnya O; Penman AD; Kharlampieva E; Bridges SL; Hergenrother RW; Singh JA; Wick TM
Int J Pharm; 2016 Jul; 509(1-2):465-476. PubMed ID: 27260133
[TBL] [Abstract][Full Text] [Related]
44. Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol.
Gao Y; Liang J; Liu J; Xiao Y
Int J Pharm; 2009 Jul; 377(1-2):128-34. PubMed ID: 19463930
[TBL] [Abstract][Full Text] [Related]
45. PREPARATION, IN VITRO AND IN VIVO CHARACTERIZATION OF HYDROPHOBIC PATCHES OF A HIGHLY WATER SOLUBLE DRUG FOR PROLONGED PLASMA HALF LIFE: EFFECT OF PERMEATION ENHANCERS.
Yaqoob A; Ahmad M; Mahmood A; Sarfraz RM
Acta Pol Pharm; 2016 Nov; 73(6):1639-1648. PubMed ID: 29634120
[TBL] [Abstract][Full Text] [Related]
46. Fabrication and characterization of matrix type transdermal patches loaded with tizanidine hydrochloride: potential sustained release delivery system.
Shahid N; Siddique MI; Razzaq Z; Katas H; Waqas MK; Rahman KU
Drug Dev Ind Pharm; 2018 Dec; 44(12):2061-2070. PubMed ID: 30081679
[TBL] [Abstract][Full Text] [Related]
47. Preparation of dual crosslinked alginate-chitosan blend gel beads and in vitro controlled release in oral site-specific drug delivery system.
Xu Y; Zhan C; Fan L; Wang L; Zheng H
Int J Pharm; 2007 May; 336(2):329-37. PubMed ID: 17223290
[TBL] [Abstract][Full Text] [Related]
48. Polysaccharides-based multiparticulated interpolyelectrolyte complexes for controlled benznidazole release.
García MC; Manzo RH; Jimenez-Kairuz A
Int J Pharm; 2018 Jul; 545(1-2):366-377. PubMed ID: 29747000
[TBL] [Abstract][Full Text] [Related]
49. Release Kinetics of Nisin from Chitosan-Alginate Complex Films.
Chandrasekar V; Coupland JN; Anantheswaran RC
J Food Sci; 2016 Oct; 81(10):E2503-E2510. PubMed ID: 27635864
[TBL] [Abstract][Full Text] [Related]
50. A novel pulsed drug-delivery system: polyelectrolyte layer-by-layer coating of chitosan-alginate microgels.
Zhou G; Lu Y; Zhang H; Chen Y; Yu Y; Gao J; Sun D; Zhang G; Zou H; Zhong Y
Int J Nanomedicine; 2013; 8():877-87. PubMed ID: 23486565
[TBL] [Abstract][Full Text] [Related]
51. Development of modified in situ gelling oral liquid sustained release formulation of dextromethorphan.
El Maghraby GM; Elzayat EM; Alanazi FK
Drug Dev Ind Pharm; 2012 Aug; 38(8):971-8. PubMed ID: 22092113
[TBL] [Abstract][Full Text] [Related]
52. QbD-Enabled Development of Novel Stimuli-Responsive Gastroretentive Systems of Acyclovir for Improved Patient Compliance and Biopharmaceutical Performance.
Singh B; Kaur A; Dhiman S; Garg B; Khurana RK; Beg S
AAPS PharmSciTech; 2016 Apr; 17(2):454-65. PubMed ID: 26238805
[TBL] [Abstract][Full Text] [Related]
53. Matrix-type transdermal films to enhance simvastatin ex vivo skin permeability.
El-Say KM; Ahmed OA; Aljaeid BM; Zidan AS
Pharm Dev Technol; 2017 Jun; 22(4):492-499. PubMed ID: 26512747
[TBL] [Abstract][Full Text] [Related]
54. Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.
Kamran M; Ahad A; Aqil M; Imam SS; Sultana Y; Ali A
Int J Pharm; 2016 May; 505(1-2):147-58. PubMed ID: 27005906
[TBL] [Abstract][Full Text] [Related]
55. Alginate-Based Hydrogel Containing Minoxidil/Hydroxypropyl-β-Cyclodextrin Inclusion Complex for Topical Alopecia Treatment.
Lopedota A; Denora N; Laquintana V; Cutrignelli A; Lopalco A; Tricarico D; Maqoud F; Curci A; Mastrodonato M; la Forgia F; Fontana S; Franco M
J Pharm Sci; 2018 Apr; 107(4):1046-1054. PubMed ID: 29183744
[TBL] [Abstract][Full Text] [Related]
56. Penetration enhancer-containing spanlastics (PECSs) for transdermal delivery of haloperidol: in vitro characterization, ex vivo permeation and in vivo biodistribution studies.
Fahmy AM; El-Setouhy DA; Ibrahim AB; Habib BA; Tayel SA; Bayoumi NA
Drug Deliv; 2018 Nov; 25(1):12-22. PubMed ID: 29219628
[TBL] [Abstract][Full Text] [Related]
57. Composite chitosan/alginate hydrogel for controlled release of deferoxamine: A system to potentially treat iron dysregulation diseases.
Rassu G; Salis A; Porcu EP; Giunchedi P; Roldo M; Gavini E
Carbohydr Polym; 2016 Jan; 136():1338-47. PubMed ID: 26572479
[TBL] [Abstract][Full Text] [Related]
58. Ultrasound-assisted transdermal delivery of alendronate for the treatment of osteoporosis.
Li B; Huang G; Ma Z; Qin S
Acta Biochim Pol; 2020 Jun; 67(2):173-179. PubMed ID: 32558528
[TBL] [Abstract][Full Text] [Related]
59. Design and characterization of calcium-free in-situ gel formulation based on sodium alginate and chitosan.
Belhadji L; HadjSadok A; Moulai-Mostefa N
Drug Dev Ind Pharm; 2018 Apr; 44(4):662-669. PubMed ID: 29172753
[TBL] [Abstract][Full Text] [Related]
60. Polyionic hydrocolloids for the intestinal delivery of protein drugs: alginate and chitosan--a review.
George M; Abraham TE
J Control Release; 2006 Aug; 114(1):1-14. PubMed ID: 16828914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
